Beyond its role in diabetes therapy, metformin also mitigates ischemia-reperfusion injury by dampening cardiomyocyte pyroptosis through the AMPK/NLRP3 pathway [200]. This evidence concerns the gene NLRP3 and diabetes mellitus.